Vanessa Marion
Physician Assistant · Palm Coast, FLNPI 1790487411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,532 and has fallen 93.0% since, to $107 in 2025.
Across 82 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$250
- Merck$243
- Johnson & Johnson$225
- Lilly USA, LLC$139
- Daiichi Sankyo Inc.$118
- Astellas Pharma US Inc$99
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,05195%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $250 |
| Merck | 6 | $243 |
| Johnson & Johnson(2 entities) | 8 | $225 |
| Lilly USA, LLC | 6 | $139 |
| Daiichi Sankyo Inc. | 5 | $118 |
| Astellas Pharma US Inc | 1 | $99 |
| Eisai Inc. | 5 | $99 |
| AstraZeneca | 4 | $87 |
| Taiho Oncology, Inc. | 3 | $79 |
| Coherus Oncology, Inc. | 4 | $75 |
| Mirati Therapeutics, Inc. | 4 | $71 |
| Gilead | 3 | $64 |
| Stemline Therapeutics Inc. | 3 | $64 |
| Puma Biotechnology, Inc. | 3 | $63 |
| Seagen Inc. | 3 | $59 |
| Genmab U.S., Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Pfizer | 2 | $53 |
| Novartis | 2 | $45 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $30 |
| Sanofi | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| G1 Therapeutics, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Pharmaessentia USA Corporation | 1 | $17 |
| GSK | 1 | $16 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,150 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 46 | $678 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Palm Coast
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.